Logo Helmholtz Zentrum München

Dr. Rui Wang-Sattler

Research group 'Metabolism'

Research Unit of Molecular Epidemiology

Institute of Epidemiology - EPI

Research interest

Our group is studying metabolic diseases (e.g. type 2 diabetes and complications). We use statistical, bioinformatical and machine learning approaches to integrate metabolomics, transcriptomics, proteomics, epigenomics, and genomics data, as well as information from public databases to better understand the pathophysiological mechanisms. This helps us to identify candidate biomarkers and drug targets, with the final goal to translate our discoveries into clinical practice.


Integration of proteomic and metabolomics data to study chronic kidney disease (CKD) in hyperglycemia

The successful candidate will work independently on a project to integrate OMICs data to study CKD in hyperglycemia. Hyperglycemia exerts detrimental effects on the kidney and is one of the leading causes of CKD. However, the onset of CKD can be partly prevented or at least delayed by increased physical activity in individuals with hyperglycemia. The aim of the project is to analyze large-scale molecular data from a population-based human cohort, and to identify candidate biomarkers of CKD and thus enabling its detection. Early detection of CKD in hyperglycemic individuals is essential for the development of personalized strategies to prevent and / or treat CKD.

We use cookies to improve your experience on our Website. We need cookies to continuously improve the services, to enable certain features and when embedding services or content of third parties, such as video player. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here:

Show detail settings
Please find more information in our privacy statement.

There you may also change your settings later.